Behavioral Health Business January 3, 2024
Despite an “urgent” need for Medicare beneficiaries to receive treatment for opioid use disorder (OUD), a low percentage receive potentially life-saving medication-assisted treatment (MAT) for the condition.
Approximately 52,000 Medicare enrollees experienced an opioid overdose in 2022, according to a report from the Office of Inspector General (OIG). However, only 18% of Medicare patients with OUD received MAT. For certain populations covered by Medicare, the number getting access to these effective therapies was even lower, with just 6% receiving MAT.
These findings demonstrate a slight increase in the percentage of Medicare enrollees who receive medication for OUD. In 2020, 16% of beneficiaries received MAT for OUD, compared to 2022’s 18%.
Research suggests that MAT is associated with lower...
Today's Sponsors
Today's Sponsor